Literature DB >> 25743125

Identification of microRNAs and their target genes in Alport syndrome using deep sequencing of iPSCs samples.

Wen-biao Chen1, Jian-rong Huang, Xiang-qi Yu, Xiao-cong Lin, Yong Dai.   

Abstract

MicroRNAs (miRNAs) are a class of small RNA molecules that are implicated in post-transcriptional regulation of gene expression during development. The discovery and understanding of miRNAs has revolutionized the traditional view of gene expression. Alport syndrome (AS) is an inherited disorder of type IV collagen, which most commonly leads to glomerulonephritis and kidney failure. Patients with AS inevitably reach end-stage renal disease and require renal replacement therapy, starting in young adulthood. In this study, Solexa sequencing was used to identify and quantitatively profile small RNAs from an AS family. We identified 30 known miRNAs that showed a significant change in expression between two individuals. Nineteen miRNAs were up-regulated and eleven were down-regulated. Forty-nine novel miRNAs showed significantly different levels of expression between two individuals. Gene target predictions for the miRNAs revealed that high ranking target genes were implicated in cell, cell part and cellular process categories. The purine metabolism pathway and mitogen-activated protein kinase (MAPK) signaling pathway were enriched by the largest number of target genes. These results strengthen the notion that miRNAs and their target genes are involved in AS and the data advance our understanding of miRNA function in the pathogenesis of AS.

Entities:  

Keywords:  Alport syndrome; Gene Ontology; Induced pluripotent stem cells (iPSCs); Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway; Solexa sequencing; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25743125      PMCID: PMC4357373          DOI: 10.1631/jzus.B1400272

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  40 in total

1.  SOAP2: an improved ultrafast tool for short read alignment.

Authors:  Ruiqiang Li; Chang Yu; Yingrui Li; Tak-Wah Lam; Siu-Ming Yiu; Karsten Kristiansen; Jun Wang
Journal:  Bioinformatics       Date:  2009-06-03       Impact factor: 6.937

2.  Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.

Authors:  X Zhang; Z Yan; J Zhang; L Gong; W Li; J Cui; Y Liu; Z Gao; J Li; L Shen; Y Lu
Journal:  Ann Oncol       Date:  2011-02-22       Impact factor: 32.976

Review 3.  Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.

Authors:  C E Kashtan
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

Review 4.  MicroRNAs in kidney physiology and disease.

Authors:  Piera Trionfini; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-11-11       Impact factor: 28.314

Review 5.  Glomerular basement membrane composition and the filtration barrier.

Authors:  Jeffrey H Miner
Journal:  Pediatr Nephrol       Date:  2011-02-15       Impact factor: 3.714

6.  The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.

Authors:  Ke Wei Zhang; Deb Colville; Rachel Tan; Colin Jones; Stephen I Alexander; Jeffrey Fletcher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

7.  Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.

Authors:  Oliver Gross; Bogdan Beirowski; Marie-Louise Koepke; Jeannine Kuck; Michael Reiner; Klaus Addicks; Neil Smyth; Eckhard Schulze-Lohoff; Manfred Weber
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

Review 8.  Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing.

Authors:  Markus Hafner; Pablo Landgraf; Janos Ludwig; Amanda Rice; Tolulope Ojo; Carolina Lin; Daniel Holoch; Cindy Lim; Thomas Tuschl
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

9.  Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker.

Authors:  Tanel Punga; Rozen Le Panse; Mats Andersson; Frédérique Truffault; Sonia Berrih-Aknin; Anna R Punga
Journal:  Ann Clin Transl Neurol       Date:  2013-12-30       Impact factor: 4.511

Review 10.  The functions of microRNAs and long non-coding RNAs in embryonic and induced pluripotent stem cells.

Authors:  Wenwen Jia; Wen Chen; Jiuhong Kang
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-10-01       Impact factor: 7.691

View more
  4 in total

1.  Gene locations may contribute to predicting gene regulatory relationships.

Authors:  Jun Meng; Wen-Yuan Xu; Xiao Chen; Tao Lin; Xiao-Yu Deng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

2.  Multiomics landscape of the autosomal dominant osteopetrosis type II disease-specific induced pluripotent stem cells.

Authors:  Chunhong Li; Yu Shangguan; Peng Zhu; Weier Dai; Donge Tang; Minglin Ou; Yong Dai
Journal:  Hereditas       Date:  2021-10-27       Impact factor: 3.271

Review 3.  Potential Renal Damage Biomarkers in Alport Syndrome-A Review of the Literature.

Authors:  Ana Marta Gomes; Daniela Lopes; Clara Almeida; Sofia Santos; Jorge Malheiro; Irina Lousa; Alberto Caldas Afonso; Idalina Beirão
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 4.  Modeling Kidney Disease with iPS Cells.

Authors:  Benjamin S Freedman
Journal:  Biomark Insights       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.